These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37653777)

  • 1. Efficacy of belimumab for severe childhood-onset systemic lupus erythematosus with diffuse proliferative glomerulonephritis: A case report.
    Hu Y; Yuan J; Wang B; Ma L; Zha Y
    Medicine (Baltimore); 2023 Aug; 102(34):e34800. PubMed ID: 37653777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Belimumab for active lupus nephritis in a young Hispanic woman intolerant to standard treatment: a case report.
    Fontana F; Alfano G; Leonelli M; Cerami C; Ligabue G; Spinella A; Citriniti G; Manzini CU; Ferri C; Cappelli G
    BMC Nephrol; 2018 Oct; 19(1):276. PubMed ID: 30342482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus.
    Trindade VC; Carneiro-Sampaio M; Bonfa E; Silva CA
    Paediatr Drugs; 2021 Jul; 23(4):331-347. PubMed ID: 34244988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of belimumab in systemic lupus erythematosus patients with severe lupus nephritis requiring renal replacement therapy.
    Liu D; Zhou Q; Wang D; Qu Y; Guo Q; Wen J; Yu Q; Ai J
    Lupus; 2022 Oct; 31(12):1456-1467. PubMed ID: 35960182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New onset of lupus nephritis in two patients with SLE shortly after initiation of treatment with belimumab.
    Staveri C; Karokis D; Liossis SC
    Semin Arthritis Rheum; 2017 Jun; 46(6):788-790. PubMed ID: 27793432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and safety of belimumab treatment in childhood-onset systemic lupus erythematosus].
    Kang M; Zhu J; Xu YJ; Li SN; Lai JM
    Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(48):3881-3885. PubMed ID: 36540927
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of a mycophenolate mofetil-refractory proliferative lupus nephritis with Belimumab in a 19-year-old woman.
    Fließer EE; Korsten P; Koziolek MJ; Niewold TB; Patschan D; Müller GA; Patschan SA
    Lupus; 2013 Dec; 22(14):1523-5. PubMed ID: 24014569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report: successful treatment of membranous lupus nephritis with belimumab in an African female immigrant.
    De Scheerder MA; Boey O; Mahieu E; Vanuytsel J; Bogaert AM
    Clin Rheumatol; 2016 Jun; 35(6):1649-53. PubMed ID: 26712500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of belimumab in treatment of Chinese childhood-onset systemic lupus erythematosus: a prospective analysis from a multicentre study.
    Wang L; Liang X; Cao Z; Wang D; Luo Y; Feng Y; Luo C; Zhi S; Huang Y; Fan Z; Wang C; Liu H; Liu J; Zhang T; Cheng Q; Xie X; Shuai L; Rong Z; Zeng P; Yu H; Lu M; Sun L; Yang S; Zhao D; Zhang W; Wu X; Li Q; Wang Y; Zhang Q; Yang J; Li X; Song H; Tang X
    Rheumatology (Oxford); 2024 May; 63(5):1437-1446. PubMed ID: 37606970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of belimumab in three cases of refractory lupus nephritis.
    Malaweera A; Dayan S; Pellicano R; Hoi A; Kitching AR; Kent JR
    Intern Med J; 2023 Oct; 53(10):1901-1906. PubMed ID: 37859540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Belimumab in childhood systemic lupus erythematosus: A review of available data.
    Chen F; Zheng Y; Chen X; Wen Z; Xu Y; Yang J; Xu K
    Front Immunol; 2022; 13():940416. PubMed ID: 35967351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
    Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of biologics in childhood systemic lupus erythematosus: a critical systematic review.
    Elshaer R; Jaber S; Odeh N; Arbili L; Al-Mayouf SM
    Clin Rheumatol; 2024 Mar; 43(3):863-877. PubMed ID: 38079010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case with good response to belimumab for lupus nephritis complicated by IgG4-related disease.
    Yamamoto M; Aochi S; Suzuki C; Nakamura S; Murakami R; Ogawa Y; Takahashi H
    Lupus; 2019 May; 28(6):786-789. PubMed ID: 30917769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the pathogenesis and treatment of childhood-onset systemic lupus erythematosus.
    Couture J; Silverman ED
    Curr Opin Rheumatol; 2016 Sep; 28(5):488-96. PubMed ID: 27341622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy.
    Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Baldovino S; Menegatti E; La Grotta R; Modena V
    Nephrol Dial Transplant; 2011 Dec; 26(12):3987-92. PubMed ID: 21385860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE.
    Dooley MA; Houssiau F; Aranow C; D'Cruz DP; Askanase A; Roth DA; Zhong ZJ; Cooper S; Freimuth WW; Ginzler EM;
    Lupus; 2013 Jan; 22(1):63-72. PubMed ID: 23263865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis.
    Atisha-Fregoso Y; Malkiel S; Harris KM; Byron M; Ding L; Kanaparthi S; Barry WT; Gao W; Ryker K; Tosta P; Askanase AD; Boackle SA; Chatham WW; Kamen DL; Karp DR; Kirou KA; Sam Lim S; Marder B; McMahon M; Parikh SV; Pendergraft WF; Podoll AS; Saxena A; Wofsy D; Diamond B; Smilek DE; Aranow C; Dall'Era M
    Arthritis Rheumatol; 2021 Jan; 73(1):121-131. PubMed ID: 32755035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
    Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.